Additional data from Minoryx’s Phase 2/3 ADVANCE clinical trial presented at American Neurological Association (ANA) 2021

por Minoryx Therapeutics

3 years ago
Minoryx, X-ALD, leriglitazone, biomarker, cerebral lesion

Presentation highlights reduction in cerebral lesion progression and the risk of developing cerebral ALD in AMN patients based on MRI and plasma biomarker data.

Collaboration between Bayer Saudi Arabia LLC, OncoDNA and Tamkin Al-Seha Medical to Test Cancer Patients for Rare NTRK Mutations in Saudi Arabia

por OncoDNA

3 years ago
biomarker, NTRK BIOMARKER, Cancer

OncoDNA, Tamkin Al-Seha Medical and Bayer Saudi Arabia announced today a new partnership to broaden access to Neurotrophic Tyrosine Receptor Kinase (NTRK) biomarker testing and identify patients eligi...

MELANOMA: Two noteworthy biomarker studies identified assessment of T cell infiltrate and clonality as a predictor of subsequent metastasis in early stage disease

por OncoDNA

4 years ago
melanoma, biomarker, metastasis

Two noteworthy biomarker studies identified assessment of T cell infiltrate and clonality as a predictor of subsequent metastasis in early stage disease, and early changes in T cell subsets and clonal...

New scientific yardstick to help early diagnosis of Alzheimer's disease

por European Commission - Joint Research Centre

6 years ago
reference material, scientific yardstick, amyloid-β 1-42, biomarker, Alzheimer's disease

The JRC released a new scientific yardstick, in the form of a certified reference material, to help early detection of Alzheimer's disease. The certified reference material will serve to calibrate ...